Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,413 | 7 | 82.0% |
| Unspecified | $1,049 | 8 | 11.6% |
| Food and Beverage | $574.78 | 7 | 6.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BLUEWIND MEDICAL | $3,222 | 4 | $0 (2024) |
| PALETTE LIFE SCIENCES, INC. | $2,113 | 2 | $0 (2023) |
| Laborie Medical Technologies Corp. | $1,450 | 2 | $0 (2022) |
| Allergan Inc. | $1,049 | 8 | $0 (2019) |
| Renovia Inc | $700.00 | 1 | $0 (2017) |
| Boston Scientific Corporation | $346.63 | 3 | $0 (2024) |
| Coloplast Corp | $99.07 | 1 | $0 (2023) |
| Caldera Medical, Inc | $56.85 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $276.11 | 3 | Boston Scientific Corporation ($253.63) |
| 2023 | $2,269 | 4 | PALETTE LIFE SCIENCES, INC. ($2,113) |
| 2022 | $1,543 | 3 | Laborie Medical Technologies Corp. ($1,450) |
| 2020 | $3,200 | 3 | BLUEWIND MEDICAL ($3,200) |
| 2019 | $1,049 | 8 | Allergan Inc. ($1,049) |
| 2017 | $700.00 | 1 | Renovia Inc ($700.00) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Boston Scientific Corporation | Upsylon (Device) | Food and Beverage | In-kind items and services | $161.06 | General |
| Category: Upsylon URO | ||||||
| 10/23/2024 | BLUEWIND MEDICAL | REVI (Device) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: BLADDER | ||||||
| 06/20/2024 | Boston Scientific Corporation | Advantage System (Device) | Food and Beverage | In-kind items and services | $92.57 | General |
| Category: Advantage URO | ||||||
| 09/14/2023 | Caldera Medical, Inc | Desara (Device) | Food and Beverage | Cash or cash equivalent | $56.85 | General |
| Category: Urogynaecology | ||||||
| 04/28/2023 | PALETTE LIFE SCIENCES, INC. | DEFLUX (Device) | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| Category: URINARY | ||||||
| 03/20/2023 | Coloplast Corp | Altis (Device) | Food and Beverage | In-kind items and services | $99.07 | General |
| Category: Women's Health | ||||||
| 03/13/2023 | PALETTE LIFE SCIENCES, INC. | DEFLUX (Device) | Consulting Fee | Cash or cash equivalent | $813.00 | General |
| Category: URINARY | ||||||
| 12/21/2022 | Laborie Medical Technologies Corp. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 10/03/2022 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $49.75 | General |
| 02/17/2022 | Boston Scientific Corporation | Solyx SIS System (Device) | Food and Beverage | In-kind items and services | $93.00 | General |
| Category: Solyx_URO | ||||||
| 12/16/2020 | BLUEWIND MEDICAL | RENOVA (Device) | Consulting Fee | In-kind items and services | $1,400.00 | General |
| Category: Neuromodulation device | ||||||
| 12/16/2020 | BLUEWIND MEDICAL | RENOVA | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Neuromodulation device | ||||||
| 05/29/2020 | BLUEWIND MEDICAL | RENOVA | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: Neuromodulation device | ||||||
| 02/25/2019 | Allergan Inc. | BOTOX (Drug) | — | In-kind items and services | $136.08 | Research |
| Study: A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE TREATMENT, 2-STAGE, DOSE FINDING STUDY EVALUATING THE EFFICACY AND SAFETY OF BOTOX INTRAVESICAL INSTALLATION IN PARTICIPANTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE. • Category: UROLOGY | ||||||
| 02/09/2019 | Allergan Inc. | BOTOX (Drug) | — | In-kind items and services | $372.32 | Research |
| Study: A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE TREATMENT, 2-STAGE, DOSE FINDING STUDY EVALUATING THE EFFICACY AND SAFETY OF BOTOX INTRAVESICAL INSTALLATION IN PARTICIPANTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE. • Category: UROLOGY | ||||||
| 02/09/2019 | Allergan Inc. | BOTOX (Drug) | — | In-kind items and services | $29.33 | Research |
| Study: A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE TREATMENT, 2-STAGE, DOSE FINDING STUDY EVALUATING THE EFFICACY AND SAFETY OF BOTOX INTRAVESICAL INSTALLATION IN PARTICIPANTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE. • Category: UROLOGY | ||||||
| 02/08/2019 | Allergan Inc. | BOTOX (Drug) | — | In-kind items and services | $7.64 | Research |
| Study: A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE TREATMENT, 2-STAGE, DOSE FINDING STUDY EVALUATING THE EFFICACY AND SAFETY OF BOTOX INTRAVESICAL INSTALLATION IN PARTICIPANTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE. • Category: UROLOGY | ||||||
| 02/07/2019 | Allergan Inc. | BOTOX (Drug) | — | In-kind items and services | $449.00 | Research |
| Study: A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE TREATMENT, 2-STAGE, DOSE FINDING STUDY EVALUATING THE EFFICACY AND SAFETY OF BOTOX INTRAVESICAL INSTALLATION IN PARTICIPANTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE. • Category: UROLOGY | ||||||
| 02/07/2019 | Allergan Inc. | BOTOX (Drug) | — | In-kind items and services | $39.27 | Research |
| Study: A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE TREATMENT, 2-STAGE, DOSE FINDING STUDY EVALUATING THE EFFICACY AND SAFETY OF BOTOX INTRAVESICAL INSTALLATION IN PARTICIPANTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE. • Category: UROLOGY | ||||||
| 02/07/2019 | Allergan Inc. | BOTOX (Drug) | — | In-kind items and services | $9.80 | Research |
| Study: A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE TREATMENT, 2-STAGE, DOSE FINDING STUDY EVALUATING THE EFFICACY AND SAFETY OF BOTOX INTRAVESICAL INSTALLATION IN PARTICIPANTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE. • Category: UROLOGY | ||||||
| 02/07/2019 | Allergan Inc. | BOTOX (Drug) | — | In-kind items and services | $5.39 | Research |
| Study: A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE TREATMENT, 2-STAGE, DOSE FINDING STUDY EVALUATING THE EFFICACY AND SAFETY OF BOTOX INTRAVESICAL INSTALLATION IN PARTICIPANTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE. • Category: UROLOGY | ||||||
| 08/16/2017 | Renovia Inc | leva Pelvic Floor Trainer (Device) | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: Urology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE TREATMENT, 2-STAGE, DOSE FINDING STUDY EVALUATING THE EFFICACY AND SAFETY OF BOTOX INTRAVESICAL INSTALLATION IN PARTICIPANTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE. | Allergan Inc. | $1,049 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 523 | 555 | $410,667 | $57,961 |
| 2022 | 12 | 623 | 643 | $462,404 | $66,586 |
| 2021 | 11 | 478 | 488 | $354,540 | $54,158 |
| 2020 | 12 | 388 | 394 | $349,902 | $49,178 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 57288 | Creation of sling around urethra in female to control leakage | Facility | 2023 | 42 | 42 | $130,536 | $14,565 | 11.2% |
| 57260 | Plastic repair of vagina and tissue separating vagina, rectum, and bladder | Facility | 2023 | 27 | 27 | $94,743 | $14,158 | 14.9% |
| 57282 | Repair of pelvic ligaments through vagina | Facility | 2023 | 33 | 33 | $72,963 | $8,615 | 11.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 81 | 96 | $23,616 | $6,559 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 60 | 60 | $24,660 | $5,060 | 20.5% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Facility | 2023 | 55 | 55 | $25,135 | $3,620 | 14.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 51 | 52 | $8,372 | $2,417 | 28.9% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Facility | 2023 | 53 | 54 | $9,072 | $1,422 | 15.7% |
| 51701 | Insertion of temporary bladder tube | Facility | 2023 | 68 | 82 | $19,680 | $1,394 | 7.1% |
| 51741 | Electronic assessment of bladder emptying | Facility | 2023 | 53 | 54 | $1,890 | $151.68 | 8.0% |
| 57288 | Creation of sling around urethra in female to control leakage | Facility | 2022 | 43 | 43 | $133,644 | $17,100 | 12.8% |
| 57260 | Plastic repair of vagina and tissue separating vagina, rectum, and bladder | Facility | 2022 | 28 | 28 | $98,252 | $13,258 | 13.5% |
| 57282 | Repair of pelvic ligaments through vagina | Facility | 2022 | 29 | 29 | $64,119 | $8,234 | 12.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 85 | 85 | $34,935 | $7,605 | 21.8% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Facility | 2022 | 72 | 72 | $32,904 | $5,226 | 15.9% |
| 57250 | Repair of herniated rectum into vaginal wall | Facility | 2022 | 12 | 12 | $29,808 | $3,706 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 46 | 47 | $11,562 | $3,325 | 28.8% |
| 51701 | Insertion of temporary bladder tube | Facility | 2022 | 111 | 128 | $30,720 | $2,310 | 7.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 47 | 49 | $7,889 | $2,139 | 27.1% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Facility | 2022 | 69 | 69 | $11,592 | $1,998 | 17.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 13 | $4,599 | $1,481 | 32.2% |
| 51741 | Electronic assessment of bladder emptying | Facility | 2022 | 68 | 68 | $2,380 | $204.77 | 8.6% |
| 57288 | Creation of sling around bladder canal (urethra) to control leakage | Facility | 2021 | 29 | 29 | $90,132 | $13,190 | 14.6% |
| 57282 | Vaginal repair of pelvic ligaments | Facility | 2021 | 31 | 31 | $68,541 | $9,389 | 13.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 95 | 95 | $39,045 | $9,001 | 23.1% |
About Holly Richter
Holly Richter is a Gynecology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083649727.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Holly Richter has received a total of $9,037 in payments from pharmaceutical and medical device companies, with $276.11 received in 2024. These payments were reported across 22 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($7,413).
As a Medicare-enrolled provider, Richter has provided services to 2,012 Medicare beneficiaries, totaling 2,080 services with total Medicare billing of $227,883. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Gynecology
- Location Birmingham, AL
- Active Since 07/11/2006
- Last Updated 02/01/2024
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1083649727
Products in Payments
- DEFLUX (Device) $2,113
- RENOVA $1,800
- RENOVA (Device) $1,400
- BOTOX (Drug) $1,049
- leva Pelvic Floor Trainer (Device) $700.00
- Upsylon (Device) $161.06
- Altis (Device) $99.07
- Solyx SIS System (Device) $93.00
- Advantage System (Device) $92.57
- Desara (Device) $56.85
- REVI (Device) $22.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecology Doctors in Birmingham
Dr. Alex Childs, M.d, M.D
Gynecology — Payments: $9,891
Dr. William Summers, M.d, M.D
Gynecology — Payments: $5,672
Dr. John Sanborn, Md, MD
Gynecology — Payments: $430.43
Dr. James Upchurch, Md, MD
Gynecology — Payments: $151.01
Dr. Dee Denson, M.d, M.D
Gynecology — Payments: $85.67
Dr. Edward Lichten, M.d, M.D
Gynecology — Payments: $71.59